Glaukos Corporation

Glaukos Corporation (GKOS) Stock Overview

Explore Glaukos Corporation’s financial performance, market position, analyst ratings, and future outlook.

GKOSNYSE
HealthcareMedical - Devices
$156.83
$1.44(0.93%)
U.S. Market opens in 6h 0m

Glaukos Corporation (GKOS)

Meyka AI Score

Z

Key Financials

Market Cap9.2B
P/E Ratio-47.70
EPS (TTM)$-0.86
ROE-0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$129.67
3 Months$121.36
1 Year Target$141.06

GKOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Glaukos Corporation (GKOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $141.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -47.70 and a market capitalization of 9.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.97%
5-Day Change
1.85%
1-Month Change
23.15%
3-Month Change
25.73%
6-Month Change
30.49%
Year-to-Date (YTD) Change
38.96%
1-Year Change
58.48%
3-Year Change
100.54%
5-Year Change
178.64%
All-Time (Max) Change
402.56%

Contact Information

949 367 9600
One Glaukos Way, Aliso Viejo, CA, 92672

Company Facts

10,940 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions